9
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Effects of the Anti-Gastric Secretory Drugs IT-066 and Omeprazole on Mitogenic Activities in the Gastric Juice of the Rat

, , , &
Pages 111-117 | Received 09 Jan 1995, Accepted 06 Jun 1995, Published online: 08 Jul 2009
 

Abstract

Background: Salivary epidermal growth factor (EGF) retains its biologic function in gastric juice and may play a physiologic role. Little is known, however, about the existence of mitogens other than EGF and the constitutional alterations of these factors in gastric juice by anti-secretagogues. Methods: The mitogenic activity was evaluated by measuring [3H]-thymidine incorporation, and the EGF contribution was determined by using a specific anti-rat EGF antibody. An H2-receptor antagonist (IT-066) and a proton pump inhibitor (omeprazole) were used to determine whether these drugs alter the relative composition of active mitogens in gastric juice. Results: Normal gastric juice significantly increased DNA synthesis. This activity was suppressed by antibody (87–88%). Both drugs increased EGF concentrations and activity dose-dependently. IT-066 specifically increased total amount and activity of EGF. Approximately 50% of this activity was reduced by boiling or antibody. Conclusions: The major mitogenic activity of normal rat gastric juice depends on EGF, and anti-secretory drugs enhance the mitogenic activity by preserving and inducing intraluminal mitogens other than EGF.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.